Search Tag: SARS-CoV-2
FDA Amends Emergency Use Authorization for Hologic’s Aptima SARS-CoV-2 Assay
2020 06 Oct
Hologic, Inc. announced today that its Aptima® SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in May, is now authorized for testing of individuals without symptoms or other reasons to suspect COVID-19 infection. This authorization follows an announcement last week... Read more
Hologic Launches Validated Pooling Protocol for COVID-19 Testing
2020 11 Aug
In Time of Extraordinary Need, New Protocol Expected to Help Laboratories Deliver Greater Quantities of Highly Accurate Molecular Test Results and Reduce Turnaround Times Hologic, Inc. announced today that it has validated use of its Aptima® and Panther Fusion® molecular diagnostic COVID-19 assays with pooled patient samples and completed... Read more
#ECR2020: COVID-19 Lessons and Questions
2020 16 Jul
During one of the plenary lectures, "COVID-19: Lessons and Questions from a Pandemic" at the #ECR2020 Virtual Congress, Dr. Marie-Pierre Revel, Professor of Radiology and Head of Cardiothoracic imaging at Hôpital Cochin in Paris said that COVID-19 was the greatest health threat that humanity has had to face since the Spanish flu. COVID-19 has... Read more